LL-37 FKR/LL-37 (17-37) - High Quality Natural Antimicrobial Peptide for R&D

The LL-37 FKR/LL-37 (17-37) is a significant Cathelicidin antimicrobial peptide produced naturally by the human body. Exceptionally refined, this peptide offers a robust resource for vital medical and clinical research, including cancer progression, suppression studies, immunomodulation, and wound healing.

• Derived from hCAP-18, a parent compound, LL-37 FKR represents the specific fragment of the LL-37 peptide, which spans across amino acids 17 to 37.
• This research-grade peptide is backed by an excellent purity level that reinforces its effectiveness in various applications.
• LL-37 FKR carries influential antimicrobial properties, making it a potent defense mechanism against numerous pathogens such as bacteria, viruses, and fungi. This ability enhances its potential for being a principal element in developing therapeutic interventions.
• With a wide application spectrum, the peptide plays a pivotal role in immunomodulation, wound healing, apoptosis, and particularly, cancer research, bringing it into the limelight of contemporary medical and clinical studies.
• Whether you need a smaller quantity (500mg) or a larger bulk order (100g), this peptide comes in a range of volumes to suit your specific requirements. The packaging includes an icebag to maintain the peptide's optimal condition during handling and transportation.
• The product is globally available with expedited and reliable delivery, with a standard lead time of 2 to 3 weeks.

LL-37 FKR/LL-37 (17-37) is your all-in-one solution for access to a high-quality antimicrobial peptide, which promises to contribute significantly to your research and development endeavors. Trust this peptide to provide superior outcomes in your medical and clinical research work.